From bad to worse - Senior IT Analyst Meditech Employee Review

2.0
Feb 28, 2022
Recommend
CEO approval
Business Outlook

Pros

They train well. If you have no experience, you can start here as a stepping stone. They almost never fire or lay people off.

Cons

The company has gone very much downhill in the last 10 years. They pay lowest in the industry across all positions. The only promote from within, often from pools which lack the necessary expertise in the field. Executive management is incompetent and out of touch with reality. Raises never match inflation, and are usually frozen for all staff anyway. Benefits have been cut. Stocks are no longer available to staff. Nepotism is rampant. Nothing is industry standard. It takes 10 people in middle management to approve a single change. There's never enough staff, and always an excuse why no one can have a hiring spot. You'll be doing 3 people's jobs in less than a year after everyone around you quits, but won't get paid for it. They require you to track every minute of your day in at least 2 different systems plus their punch clock system. They're a tech company who doesn't want their staff to work from home. They excel at micromanagement from all levels. This company makes the movie Office Space look like it would be a vast improvement from where it is today.

Explore other reviews about Meditech

5.0
Nov 23, 2025
Recommend
CEO approval
Business Outlook

Pros

Pretty good environment to work in

Cons

A lot of travel which is both good and bad

2.0
Jul 12, 2026
Recommend
CEO approval
Business Outlook

Pros

MEDITECH is surviving, which wasn't a certainty ten years ago. Considering the low starting salaries for greater Boston, the company tends to be less selective in who they hire compared to other employers. Even with the effect that AI is having on tech hiring.

Cons

The market was MEDITECH's to lose, and they lost it. Without HCA as a customer MEDITECH would be finished. Considerations for job applicants such as inclusiveness and work/life balance are largely irrelevant, as the company's long-term prospects for success are doubtful. MaaS subscriptions don't bring in enough money to make up for the business that was lost to market leader Epic Systems. I am a MEDITECH shareholder, so I see the financial reports. Although I'm pleased that dividends continue to be paid, they are draining the company of badly needed cash to fund a turnaround.

5
See reviews by: Helpful|Rating|Date|All